Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Most patients schedule their next shot before the previous one fully wears off to keep B12 levels steady
This means higher IGF-1 levels increase risk for certain cancers and make some more difficult to treat
Without those, we are prescribing blindly." Bottom line: Is Mochi Health right for you
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
But the oral Wegovy pill was approved in late 2025 and pharmaceutical companies are reportedly working on more pills that will likely give patients more options in the future.
US$ 22.07
US$ 27.49
US$ 27.15
US$ 23.62
US$ 23.24
US$ 24.28
US$ 21.33
US$ 28.45
US$ 26.51
US$ 23.11
US$ 21.70
